The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Any reason why the clinic numbers have not gone up? 450 at year end seems impossible
I was thinking that this morning. No new clinics, no comms, nothing. Alarming
Shocking that we should find out this way tho :(. Thanks LeBadinho. Great news
Great share. Q2 results will follow shortly after the AGM.
No new clinics and covid testing taking centre stage again on the websites. I hope there is something going on in the background. Marc has gone very quiet with bestowing the virtues on blood testing. It feels appropriate to have an update at this stage.
I am good thanks. Your right. It like watching paint dry. They have gone very quiet.
God its quiet. Hope your all well. Even you Skycity :)
Skycity knows this too. He is just being contrary and rude.
Good to have you around Lebadinho. I like your positivity. I agree with your sentiment.
Gettem I sympathise with your situation as I am in a worse position than you. However I disagree that the CEO is clueless. Geremy has evolved the business to a changing market and adapted accordingly. I am confused by the opening of a clinic in Canada. That was a weird decision and we were sold out with the purchase of Stillcanna but we are not on life support yet like other companies. We are clearly making money. If Goodbody can deliver with 600 clinics we are going to be in a strong position for the future. Unfortunately, this will take time. Time that money cannot afford. We could have invested elsewhere and made a greater return. Geremy is accountable for that. The future of our invested money all depends on the success of blood testing at the moment. The lack of new clinics being registerd in the last 3 weeks suggests that it could go either way. We are all in this for the same reason so lets all hope the big man delivers...
Different agenda back then, as Skycity knows. It was about cbd. Geremy actually said 200. You are right. Its ok to change direction if something is not working. I do believe big things will be announced but after we have closed down in Canada.
Thanks. 600-650 by Q3 is a very big ask. If there is a big player on board that would make sense.
The projected figures given in the Arden report are nowhere near where we are today. LeBadinho is best placed to tell us how many new pharmacies we have had join us in the last 4 weeks. Whatever the number it goes against the comments of Marc Howell. " we are recruiting pharmacies as fast as we can" It is all very slow progress. Some comment on this from Geremy/Marc would help. Clearly cashflow is paramount
Worrying.....
Good time for Goodbody to acquire 18,248,107 shares through the NCIB. Anyone would think it was contrived????
I agree. Henry was either a mistake or the fall guy who got £750k for his troubles. Did not go downhill tho. Generating revenues of £17m from covid when you are a cbd company is sheer brilliance. Producing hand sanitiser during lockdown was inventive. Moving into bloods and well being at a time when the NHS is buckling is forward thinking. Whats not to like, other than the share price?
Geremy definitely did not take his eye off the ball. He has adapted to market conditions and regulations imposed on the sale of cbd and covid. I strongly believe that this business will come good. Geremy is brilliant at seeking out new opportunities. I appreciate the fact that he is embarrassed by the share price..
LeBadinho, Goodbody bought Stillcanna at great cost to shareholders at the time. We gave 3 of our shares for one of Stillcanna's. I saw my money shrink by two thirds straight after the deal. I had close to 1m shares at the time. I then bought more to lower my average. The share price has since halved. Yes, it risky because if they do it again I will have thrown good money after bad. Goodbody got the cash from Stillcanna that they wanted and we paid the price for it. Very honest interview from Geremy. He has told long suffering shareholders to hang in there. So, I will.....I have faith. Has to be seen as an inventment, not a punt
The danger here is another reverse takeover whereby our current stake gets diluted further. Its risky
Best place for them. The board have acknowledged that things are going to take some time to get to where they need to be. Clinic openings have been painfully slow. If blood tests don't take off we will be struggling. Looking at Yooma figures for cbd are not encouraging either. Market cap tho is not a reflection of our assets. We are worth alot more than that